Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seghatchian

Showing results (1-10 of 443) with videos related to

Pageof 45
Sort By:
Transfusion Science|April 20, 2000
The Second International Forum on variant CJD and leucodepletion: UKSeghatchian
Transfusion Science|April 20, 2000
Laboratory and clinical aspects of platelet concentratesSeghatchian
Transfusion Science|August 5, 2000
Editorial: focus on quality assurance research developmentSeghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 2, 2016
Cross-talk on quality/safety of blood derived serum eye dropsJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 16, 2023
What's happening CAR T cell immunotherapyJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 28, 2020
The state of plasma fractionation in technologically disadvantaged countries and current perspectives on the classification and applications of platelet-derived bio-products used in regenerative medicineJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 31, 2022
An appraisal of the latest achievements on platelet lysate designed for clinical opportunities in regenerative medicine and cellular therapyJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 6, 2022
Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 2, 2017
Evolving concepts of the RBC storage lesion using Omics and other novel diagnostic toolsJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 5, 2021
Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmountJerard Seghatchian
Pageof 45

Showing results (1-10 of 443) with videos related to

Sort By:
Pageof 45
Transfusion Science|April 20, 2000
The Second International Forum on variant CJD and leucodepletion: UKSeghatchian
Transfusion Science|April 20, 2000
Laboratory and clinical aspects of platelet concentratesSeghatchian
Transfusion Science|August 5, 2000
Editorial: focus on quality assurance research developmentSeghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 2, 2016
Cross-talk on quality/safety of blood derived serum eye dropsJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 16, 2023
What's happening CAR T cell immunotherapyJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 28, 2020
The state of plasma fractionation in technologically disadvantaged countries and current perspectives on the classification and applications of platelet-derived bio-products used in regenerative medicineJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 31, 2022
An appraisal of the latest achievements on platelet lysate designed for clinical opportunities in regenerative medicine and cellular therapyJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 6, 2022
Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 2, 2017
Evolving concepts of the RBC storage lesion using Omics and other novel diagnostic toolsJerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 5, 2021
Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmountJerard Seghatchian
Pageof 45